Skip to main content
FinSpry Logo
FinSpry
BIOA logo
BIOA
(NASDAQ)
BioAge Labs, Inc.
$17.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BioAge Labs, Inc. (BIOA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for BioAge Labs, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Strong Buy
Based on 7 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$53.00
↑ 202.86% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest BIOA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Joseph Stringer
Needham
Strong BuyInitiates
$50.00
Samantha Semenkow
Citi
Strong BuyMaintains
$15.00 → $52.00
Jay Olson
Oppenheimer
BuyInitiates
$60.00
Roger Song
Jefferies
Strong BuyUpgrades
$9.00 → $62.00
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$73.00
Yasmeen Rahimi
Piper Sandler
BuyInitiates
$73.00
OpenAI Biotechnology
TipRanks - OpenAI
HoldReiterates
$22.50 → $21.00
Andy Hsieh
William Blair
HoldReiterates
-
Samantha Semenkow
Citi
BuyReiterates
$15.00

Frequently Asked Questions

What is the analyst consensus rating for BIOA?

The analyst consensus rating for BIOA is "Strong Buy" based on 7 analyst recommendations.

What is the average price target for BIOA?

The average 12-month price target for BIOA is $53.00, representing an upside of 202.9% from the current price of $17.50.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.